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ABSTRACT: We report herein an efficient chemical synthesis of homogeneous human E-cadherin N-linked glycopeptides
consisting of a heptapeptide sequence adjacent to the Asn-633 N-glycosylation site with representative N-glycan structures, including
a conserved trisaccharide, a core-fucosylated tetrasaccharide, and a complex-type biantennary octasaccharide. The key steps are a
chemoselective on-resin aspartylation using a pseudoproline-containing peptide and stereoselective glycosylation using glycosyl
fluororide as a donor. This synthetic strategy demonstrates potential utility in accessing a wide range of homogeneous N-linked
glycopeptides for the examination of their biological function.
E-Cadherin is an N-glycoprotein cell−cell adhesion receptor
that is critical in epithelial tissue formation, cell polarity, and
differentiation.1 E-Cadherin mediates cell−cell adhesion via
the assembly of multiprotein complexes linked to the actin
cytoskeleton.2 In addition to phosphorylation3 and O-
glycosylation,4 E-cadherin can be N-glycosylated by high-
mannose, hybrid, and complex N-glycans. Human E-cadherins
have four potential N-glycosylation sites at residues Asn-554,
-566, -618, and -633 in the EC4 and EC5 domains (Figure 1a).
During tumor development and progression, the quantitative
and qualitative changes in N-glycosylations affect the stability,
trafficking, and thus cell adhesion properties of E-cadherin.5
Importantly, different glycoforms of E-cadherins are promising
cancer biomarkers, with potential clinical application to
improve the management of patients, and are targets for the
development of new therapies. The biological studies of N-
glycosylation of E-cadherins often require well-defined N-
glycopeptides, which however are difficult to acquire from
natural sources due to their microheterogeneity. The
developed chemical and enzymatic synthesis strategies, along
with native chemical ligation (NCL), enabled the synthesis of
complex N-glycopeptides and N-glycoproteins with significant
biological importance.6−10 However, those methods still suffer
from poor stereoselective control and low efficiency.11
We report herein an efficient chemical synthesis of human E-
cadherin N-linked glycopeptides consisting of a heptapeptide
sequence adjacent to the N-glycosylation site on Asn-633 with
representative N-glycan structures, including a conserved
trisaccharide (1), a core-fucosylated tetrasaccharide (2), and
a complex-type biantennary octasaccharide (3). As for the
efficient formation of a glycopeptide linkage, we developed a
chemoselective on-resin aspartylation that relies on the
coupling between glycosyl amine 5, 6, or 7 (Figure 1b) and
pseudoproline-containing peptide 4 on a solid-phase support,
which has been proven to suppress the formation of
aspartimide. In the efforts to synthesize complex N-glycan
structures, different strategies have been developed by several
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research groups.12 Considering the synthetic efficiency, we
envisioned protected biantennary octasaccharide 8 could be
assembled by successive coupling of trisaccharyl and
disaccharyl donors, either thioglycoside or glycosyl fluorides,
onto the 3- and 6-OH positions of the core trisaccharide by
stereoselective convergent glycosylations.13−16
Thus, all tri- and disaccharyl donors for the installation of
branch moieties, including 15 and 17−19, can be synthesized
in a unified manner from reported building blocks (Scheme
1).13 In detail, the glycosylation coupling of trichloroacetimi-
date donor 10 with acceptor 11 under the activation of
TMSOTf in CH2Cl2 at −78 °C afforded disaccharide 12 in
92% yield. The 4-OAc group was removed by the treatment of
NaOCH3 in CH3OH to provide 13. Glycosylation of 13 with
galactosyl bromide donor 14 under the activation of AgOTf
gave trisaccharide 15. Disaccharide 18 was synthesized by 4-O-
benzylation of 13. Then, glycosides 15 and 18 were subjected
to oxidative hydrolysis with NBS followed by treatment with
DAST in CH2Cl2 to afford glycosyl fluorides 17 and 19,
respectively.
Next, protected core trisaccharide 29 and core-fucosylated
tetrasaccharide 30 were readily prepared from the common β-
linked disaccharyl donor 24 in a convergent [2+1] and [2+2]
manner, respectively (Scheme 2). Acceptor 21 was synthesized
from known intermediate 20 in three steps. Then using Crich’s
stereoselective β-mannosylation approach,17,18 mannosyl thio-
glycoside 22 was coupled with 21 to provide 23, of which the
anomeric TDS protection was removed by HF-Py, and the
resulting hemiacetal was treated with CF3C(NPh)Cl to afford
N-phenyl trifluoroacetimidate donor 24. As an acceptor for the
assembly of core-fucosylated tetrasaccharide 30, disaccharide
28 was synthesized by the regioselective glycosylation at 6-OH
of acceptor 27 with fucosyl thioglycoside 26 in the presence of
CuBr2 and Bu4NBr. Then, common disaccharyl donor 24 was
coupled with acceptor 25 or 28 by treatment with TMSOTf to
provide core trisaccharide 29 or core-fucosylated tetrasacchar-
ide 30, respectively, each of which was subjected to further
protecting group manipulations to give 31 or 32, respectively.
With all synthetic modules in hand, the assembly of
biantennary octasaccharide 36 was investigated, commencing
from the 3-O-glycosylation of core trisaccharide 29 with
trisaccharyl thioglycoside donor 15 (Scheme 3). The coupling
was performed under the activation of NIS/AgOTf in Et2O at
0 °C, providing the desired α-configured hexasaccharide 33 in
Figure 1. (a) Structural illustration of E-cadherin N-glycosylation
sites and target molecules. (b) Synthetic strategy.
Scheme 1. Synthesis of Di- and Trisaccharide Building
Blocks
Scheme 2. Synthesis of the Core Trisaccharide and
Tetrasaccharide
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96% yield with poor stereoselectivity (2.5:1 α:β ratio).17,19
Then, we turned to the use of glycosyl fluoride and the
coupling of trisaccharyl fluoride 17 with 29 proceeded in the
presence of Cp2HfCl2/AgOTf in toluene at −40 °C to give
hexasaccharide 33 in 73% yield with an improved selectivity
(5:1 α:β ratio). When AgOTf was replaced with AgClO4, the
stereoselectivity was enhanced to a ratio of 7:1. Next, the
resulting hexasaccharide 33 was deprotected in the presence of
TsOH and EtSH, providing diol acceptor 34 in 91% yield.20
The subsequent regioselective glycosylation at 6-OH was then
studied. The use of thioglycoside donor 18 delivered the fully
protected biantennary N-glycan 35 in 52% yield with an α:β
ratio of 2.5:1. Interestingly, a similar counteranion influence on
stereoselectivity was observed in glycosylation of 34 with
disaccharyl fluoride 19, wherein the stereoselectivity was
enhanced from 2.5:1 to 3.3:1 (α:β) by changing AgOTf to
AgClO4. Intermediate 35 was subjected to further protecting
group manipulations to give 36.
After the synthesis of the N-glycan part, we turned our
attention to the peptide segment and subsequent aspartylation
coupling (Scheme 4). To prevent the formation of the
aspartimide side product, we opted to incorporate a
pseudoproline unit at the consensus-sequence Thr residue as
used by the groups of Danishefsky and Unverzagt.21 Thus, we
prepared the protected heptapeptides 39 using pseudoproline
dipeptide building block 37′ corresponding to a Trp-Thr
sequence from preloaded acid-sensitive 2-chlorotrityl resin by
Fmoc solid-phase peptide synthesis (SPPS) on an automated
synthesizer. After the assembly of resin-bound heptapeptide
38, Pd(PPh3)4 was used in the presence of phenylsilane to
Scheme 3. Synthesis of Octasaccharide 36
Scheme 4. Synthesis of Glycopeptides by On-Resin Aspartylation Using a Pseudoproline Peptide
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remove the allyl ester group to provide crude carboxylic acid
39 on the solid phase.
Having peptide acid 39 in hand, we set up to synthesize
glycopeptide 1 with a core trisaccharide N-glycan. Pseudopro-
line-containing peptide 39 on resin was readily coupled with
unprotected amine 40, prepared from 31 by global
deprotection and amination with NH4HCO3, under Lansbury
aspartylation conditions using DEPBT as a coupling reagent.22
The formation of the desired glycopeptide 41 was accom-
panied by a large amount of asparagine byproduct 43 with a
ratio of 47:53 (41:43). Subsequent addition of a TFA cocktail
(TFA/DODT/TIPS/H2O) served to remove all protecting
groups and release the glycopeptide from the resin, thereby
providing the target glycopeptide 1 in 32% yield over four
steps.
Despite the successful synthesis of 1, the observation of
asparagine formation prompted us to use partly protected
glycosyl as the coupling partner in the synthesis of
glycopeptides 2 and 3. To access the partly protected glycosyl
amine 44, tetrasaccharyl azide 32 was subjected to
deprotection of acetyl ester groups to avoid late-stage
deacetylation that might complicate the synthesis, followed
by rapid reduction of the azido group by hydrogenation under
the catalysis of PtO2 to minimize the potential anomerization
at the reducing end. 44 was coupled with pseudoproline-
containing peptide 39 on solid phase under PyAOP/NMM
conditions in DMF, and the resulting glycopeptide was
released from the resin by a cocktail (TFE/HOAc/DCM).
As anticipated, the desired glycopeptide 45 was obtained with
a trace amount of aspartimide 46 and asparagine 47 side
products, which demonstrated the huge advantages of using
the pseudoproline-containing peptide and partly protected
glycosyl amine in aspartylation coupling. Next, the protected
glycopeptide 45 was then subjected to debenzylation by
hydrogenolysis under Pd/C in CH3OH and subsequent global
deprotection using a TFA cocktail (TFA/phenol/TIPS/H2O),
giving target glycopeptide 2 in 41% yield over five steps.
Having established the optimal synthetic strategy, we
continued the synthesis of glycopeptide 3 bearing a complex-
type biantennary octasaccharide. Following the same proce-
dure, the synthesis of octasaccharide glycopeptide 49
proceeded smoothly without the formation of aspartimide 50
and asparagine 51 byproducts. The benzyl groups in 49 were
removed by hydrogenolysis under Pd/C in CH3OH. It is
worth noting that debenzylation over Pd/C proceeded with
partial over-reduction of indole to indoline as indicated by
MALDI-TOF-MS analysis. In addition, the use of a catalytic
amount of Pd(OH)2/C instead led to quantitative formation of
the indoline derivative. To our delight, the indoline derivative
can be readily dehydrogenated by the treatment of Pd/C in
THF/H2O to afford the pure indole derivative. Finally, the
deprotection using a TFA lotion (TFA/phenol/TIPS/H2O)
provided the target glycopeptide 3 in 34% yield over five steps.
The chemical structures of 1−3 were determined on the bass
of a combination of two-dimensional NMR techniques.23,24
In conclusion, we describe herein an efficient synthesis of
homogeneous human E-cadherin N-linked glycopeptides
consisting of a heptapeptide sequence adjacent to the Asn-
633 N-glycosylation site and representative N-glycan struc-
tures, including a conserved trisaccharide, a core-fucosylated
tetrasaccharide, and a complex-type biantennary octasacchar-
ide. We developed a chemoselective on-resin aspartylation that
relies on the coupling between a partly protected glycosyl
amine and a pseudoproline-containing peptide, which have
been proven to eliminate the aspartimide and asparagine side
products. As for the assembly of the biantennary N-glycan
moiety, oligosaccharyl donors were utilized to introduce the C-
3/C-6 branches via convergent glycosylations, wherein the
stereoselective control was strongly influenced by the glycosyl
donor leaving groups (e.g., SEt and F) as well as the solvent
and additives. This synthetic strategy demonstrates potential
for accessing a wide range of homogeneous N-linked
glycopeptides for the study of their biological function.
■ ASSOCIATED CONTENT
*sı Supporting Information
The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acs.orglett.0c02971.




Peng George Wang − School of Medicine, Southern University
of Science and Technology, Shenzhen 518055, China;
Department of Chemistry, Georgia State University, Atlanta,
Georgia 30303, United States; orcid.org/0000-0003-3335-
6794; Email: wangp6@sustech.edu.cn
Jun Zhou − Department of Chemistry, Georgia State University,
Atlanta, Georgia 30303, United States; R&D Headquarters,
WuXi AppTec, Shanghai 200131, China; Email: jun.m.zhou@
outlook.com
Authors
Chen Zeng − School of Medicine, Southern University of Science
and Technology, Shenzhen 518055, China; orcid.org/0000-
0001-5350-7639
Bin Sun − School of Medicine, Southern University of Science and
Technology, Shenzhen 518055, China
Xuefeng Cao − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Hailiang Zhu − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Olawale Micheal Oluwadahunsi − Department of Chemistry,
Georgia State University, Atlanta, Georgia 30303, United States
Ding Liu − Department of Chemistry, Georgia State University,
Atlanta, Georgia 30303, United States
He Zhu − Department of Chemistry, Georgia State University,
Atlanta, Georgia 30303, United States
Jiabin Zhang − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Qing Zhang − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Gaolan Zhang − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Christopher Andrew Gibbons − Department of Chemistry,
Georgia State University, Atlanta, Georgia 30303, United States
Yunpeng Liu − Department of Chemistry, Georgia State
University, Atlanta, Georgia 30303, United States
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.orglett.0c02971
Author Contributions
∥C.Z. and B.S. contributed equally to this work.
Organic Letters pubs.acs.org/OrgLett Letter
https://dx.doi.org/10.1021/acs.orglett.0c02971
Org. Lett. 2020, 22, 8349−8353
8352
Notes
The authors declare no competing financial interest.
■ REFERENCES
(1) (a) Song, J.-H.; Huels, D. J.; Ridgway, R. A.; Sansom, O. J.;
Kholodenko, B. N.; Kolch, W.; Cho, K.-H. Cell Rep. 2014, 7, 94−103.
(b) Bondow, B. J.; Faber, M. L.; Wojta, K. J.; Walker, E. M.; Battle, M.
A. Dev. Biol. 2012, 371, 1−12. (c) Tan, C. W.; Hirokawa, Y.;
Gardiner, B. S.; Smith, D. W.; Burgess, A. W. PLoS One 2013, 8,
No. e78519. (d) Solanas, G.; Cortina, C.; Sevillano, M.; Batlle, E. Nat.
Cell Biol. 2011, 13, 1100−1107. (e) Wang, F.; Scoville, D.; He, X. C.;
Mahe, M. M.; Box, A.; Perry, J. M.; Smith, N. R.; Lei, N. Y.; Davies, P.
S.; Fuller, M. K.; et al. Gastroenterology 2013, 145, 383−395.
(2) (a) Takeichi, M. Curr. Opin. Cell Biol. 1995, 7, 619−627.
(b) Nollet, F.; Berx, G.; van Roy, F. Mol. Cell Biol. Res. Commun.
1999, 2, 77−85. (c) Yap, A. S. Cancer Invest. 1998, 16, 252−261.
(3) (a) McEwen, A. E.; Maher, M. T.; Mo, R.; Gottardi, C. J. Mol.
Biol. Cell 2014, 25, 2365−2374. (b) Matteucci, E.; Ridolfi, E.;
Desiderio, M. A. Cell. Mol. Life Sci. 2006, 63, 2016−2026.
(4) Carvalho, S.; Oliveira, T.; Bartels, M. F.; Miyoshi, E.; Pierce, M.;
Taniguchi, N.; Carneiro, F.; Seruca, R.; Reis, C. A.; Strahl, S.; Pinho,
S. S. Oncotarget 2016, 7, 65231−65246.
(5) (a) Zhao, H.; Liang, Y.; Xu, Z.; Wang, L.; Zhou, F.; Li, Z.; Jin, J.;
Yang, Y.; Fang, Z.; Hu, Y.; Zhang, L.; Su, J.; Zha, X. J. Cell. Biochem.
2008, 104, 162−175. (b) Liwosz, A.; Lei, T.; Kukuruzinska, M. A. J.
Biol. Chem. 2006, 281, 23138−23149. (c) Pinho, S. S.; Osoŕio, H.;
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Pöhner, C.; Schwarzinger, S.; Unverzagt, C. Angew. Chem., Int. Ed.
2012, 51, 11566−11570.
(22) (a) Anisfeld, S. T.; Lansbury, P. T. J. Org. Chem. 1990, 55,
5560−5562. (b) Cohen-Anisfeld, S. T.; Lansbury, P. T. J. Am. Chem.
Soc. 1993, 115, 10531−10537.
(23) (a) Duus, J. Ø.; Gotfredsen, C. H.; Bock, K. Chem. Rev. 2000,
100, 4589−4614. (b) Breton, R. C.; Reynolds, W. F. Nat. Prod. Rep.
2013, 30, 501−524.
(24) (a) Kozminski, W.; Nanz, D. J. Magn. Reson. 1997, 124, 383−
392. (b) Kozminski, W.; Nanz, D. J. Magn. Reson. 2000, 142, 294−
299. (c) Palermo, G.; Riccio, R.; Bifulco, G. J. Org. Chem. 2010, 75,
1982−1991. (d) Nilewski, C.; Geisser, R. W.; Ebert, M.-O.; Carreira,
E. J. Am. Chem. Soc. 2009, 131, 15866−15876. (e) Morinaka, B. I.;
Molinski, T. F. Org. Lett. 2011, 13, 6338−6341.
Organic Letters pubs.acs.org/OrgLett Letter
https://dx.doi.org/10.1021/acs.orglett.0c02971
Org. Lett. 2020, 22, 8349−8353
8353
